Developer docs
API playgroundTry for free, no card

Search company profiles

ABF Ingredients

Full company profile

uuid000g6ip

Namestring
ABF Ingredients
Legal namestring
ABF Ingredients Limited
Company typeenum
Private
Founded yearint
2003
Descriptiontext

ABF Ingredients (ABFI) is the specialty ingredients division of Associated British Foods plc, a London-listed conglomerate, operating as a private subsidiary headquartered in Peterborough, United Kingdom with 501-1,000 employees. The company is structured as six empowered business units — AB Enzymes, ABITEC Corporation, Biotexia, Ohly, PGP International, and SPI Pharma — each focused on a distinct ingredient technology and end-market. ABFI's portfolio spans enzymes for food, feed, and industrial processing; specialty lipids and emulsifiers for pharmaceutical, nutritional, and food applications; yeast extracts and savory flavors (Ohly, with 190 years of Hamburg production heritage); extruded grain and protein crisps; pharmaceutical excipients, vaccine adjuvants, and drug delivery systems; and bioactives for health and nutrition applications. Customer end-markets include food manufacturers, pharmaceutical companies, health and nutrition brands, animal feed manufacturers, and industrial processors, served across at least 28 countries in North America, Europe, Latin America, Asia, Africa, and Oceania. Technology differentiation is anchored in long-tenured proprietary processes (yeast fermentation, enzyme engineering, lipid chemistry) rather than AI or software; products such as VERON POLARUM (enzyme), ActiMask (taste masking), and Q-SAP (saponin adjuvants) reflect the company's R&D positioning.

The business operates a B2B specialty ingredients model, generating revenue through negotiated multi-year supply contracts with manufacturers rather than standardized list pricing. Distribution combines direct enterprise sales with channel partnerships (DKSH for lipids in select regions, Palmer Holland in the US, Lehmann & Voss&Co. in Poland) and customer-facing infrastructure such as Ohly's Customer Innovation Center in Chicago. Recent strategic posture is one of capacity expansion and portfolio consolidation: a $247-270 million Ohly biomanufacturing campus is under development in Eau Claire, Wisconsin (three phases through 2035), a new spray drying tower has opened in Hamburg, three health and nutrition brands (Fytexia, ABbiotek Health, Anzchem) have been unified into a single business, and the parent ABF announced a 2026 demerger separating Primark retail from the Food and Ingredients group (FoodCo). FY2023 segment revenue was £2,157 million with £214 million adjusted operating profit; FY2025 segment revenue declined 2% (1% at constant currency) due to US consumer weakness in bakery ingredients and increased investment. Leadership transitioned in April 2024 when Jeremy Xu succeeded Fabienne Saadane-Oaks as CEO.

Short descriptiontext

ABF Ingredients is the specialty ingredients division of Associated British Foods plc, operating six business units (AB Enzymes, ABITEC, Biotexia, Ohly, PGP International, SPI Pharma) that supply enzymes, yeast extracts, specialty lipids, pharmaceutical excipients, bioactives, and extruded crisps to food, pharmaceutical, health/nutrition, animal health, and industrial manufacturers across 28+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersPeterborough, United Kingdom
HQ citystring
Peterborough
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty ingredients supplier, enzyme technology, yeast extracts, pharmaceutical excipients, specialty lipids
Industry4 codes
1Food-Grade Additives & Functional Ingredients Trading/Wholesale
CodeAFAIAKAIPrimaryYes
2Baking Ingredients & Mixes Wholesale (Flour, Sugar, Yeast, Improvers)
CodeAFAIAFADPrimaryNo
3Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium)
CodeAFAKAJADPrimaryNo
4Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryNo
NAICS code3 codes
  • Food Manufacturing311
  • Fats and Oils Refining and Blending311225
  • Flavoring Syrup and Concentrate Manufacturing31193
SIC code3 codes
  • Miscellaneous Food Preparations & Kindred Products2090
  • Food And Kindred Products2000
  • Fats & Oils2070
Product category
Specialty Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Ingredients B2B Sales
TypeOne Time License
Description

ABF Ingredients generates revenue through the sale of specialty ingredients to food, pharmaceutical, health and nutrition, animal health, and industrial manufacturers. The company operates six business units serving diverse markets with a focus on functional ingredients, enzymes, yeast extracts, pharmaceutical excipients, and specialty lipids.

abfingredients.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1B2B specialty ingredients pricing - negotiated contracts
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is negotiated on a per-contract basis for industrial buyers of specialty ingredients, enzymes, pharmaceutical excipients, and functional food components.

abfingredients.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Ohly
Description

Specialty yeast extracts and yeast products for food flavor, pharmaceutical, and industrial applications

abfingredients.com
+5 more records
Core offering1 text field

ABF Ingredients is the specialty ingredients division of Associated British Foods, comprising six empowered businesses that manufacture and sell functional ingredients to industrial customers. The portfolio spans enzymes (AB Enzymes), specialty lipids and emulsifiers (ABITEC), bioactives (Biotexia), yeast extracts and savory flavors (Ohly), extruded grain and protein crisps (PGP International), and pharmaceutical excipients and delivery systems (SPI Pharma). Products are sold to food, pharmaceutical, health and nutrition, animal health, and industrial manufacturers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 85% improvement in safety metrics since the HSE Awards programme's inception
+2 more records
Product overview1 text field

ABF Ingredients (ABFI) is the specialty ingredients division of Associated British Foods, comprising six empowered businesses offering a diverse portfolio of specialty ingredients across Health, Nutrition, Food, Animal Health, Pharmaceuticals, and Industrial sectors. The portfolio includes AB Enzymes (enzyme solutions), ABITEC Corporation (specialty lipids and emulsifiers), Biotexia (health and nutrition ingredients), Ohly (yeast extracts and savory flavors), PGP International (protein-based ingredients and extruded crisps), and SPI Pharma (pharmaceutical excipients and delivery systems). Products span antacid actives, bioactives, culinary powders, enzymes, extruded crisps, pharmaceutical excipients, specialty flours, specialty lipids, surfactants and emulsifiers, taste masking technology (ActiMask), vaccine adjuvants, and yeast extracts. The unified Health & Nutrition business combines Fytexia, ABbiotek Health, and Anzchem focusing on immune health, digestive health, mobility health, metabolic health, brain health, and women's health.

Product and service18 records
1AB Enzymes
CategoryBusiness Unit
Description

Enzyme solutions for food, animal feed, and industrial applications, including baking, beverages, grain and oil seed processing, cleaning products, lubricants, and textiles.

2ABITEC Corporation
CategoryBusiness Unit
Description

Specialty lipids and emulsifiers for pharmaceutical, food, nutritional, and industrial applications, including surfactants and functional lipid solutions.

3Biotexia
CategoryBusiness Unit
Description

Health and nutrition ingredients business focused on scientifically supported bioactives for human health applications including weight management, immune health, and quality of life.

4Ohly
CategoryBusiness Unit
Description

Yeast extracts and specialty ingredients for savory flavors, food, beverage, pharmaceutical, and industrial applications, with 190 years of production heritage in Hamburg.

5PGP International
CategoryBusiness Unit
Description

Protein-based ingredients and extruded grain and protein crisps for snack and food applications including alternative proteins and specialty flours.

6SPI Pharma
CategoryBusiness Unit
Description

Pharmaceutical excipients, vaccine adjuvants, and drug delivery systems including taste masking technology and parenteral products for pharmaceutical formulations.

7Antacid Actives
CategoryProduct
Description

Active pharmaceutical ingredients for antacid formulations used by pharmaceutical manufacturers.

8Bioactives
CategoryProduct
Description

Bioactive ingredients for health and nutrition applications supporting wellness and functional food formulations.

9Culinary Powders
CategoryProduct
Description

Powder-based culinary ingredients for food processing and manufacturing applications.

10Extruded Crisps
CategoryProduct
Description

Extruded grain and protein crisps for snack and food applications.

11Enzymes
CategoryProduct
Description

Enzyme products for various industrial, food, and feed applications including VERON POLARUM for butter-rich recipes.

12Pharmaceutical Excipients
CategoryProduct
Description

Excipient ingredients for pharmaceutical formulations and drug delivery systems.

13Specialty Flours
CategoryProduct
Description

Specialty flour products for food manufacturing and processing.

14Specialty Lipids
CategoryProduct
Description

Specialty lipid ingredients for pharmaceutical, nutritional, and food applications.

15Surfactants and Emulsifiers
CategoryProduct
Description

Surface-active agents and emulsifiers for various industrial and food applications.

16Taste Masking Technology
CategoryProduct
Description

Technologies to mask unpleasant tastes in pharmaceutical and nutritional products, including ActiMask.

17Vaccine Adjuvants
CategoryProduct
Description

Adjuvant ingredients for vaccine formulations including saponin-based adjuvants for human and veterinary vaccines.

18Yeast Extracts
CategoryProduct
Description

Yeast extract products for flavor enhancement and nutritional applications, including high nucleotide yeast extracts.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-17
Description

SPI Pharma and Q-Vant Biosciences partnership combining Q-Vant's sustainable saponin extraction technology with SPI's global reach and pharmaceutical servicing expertise. Includes investment in expansion of Q-Vant's proprietary Q-SAP technology and exclusive commercial agreement for sustainable saponin adjuvants for veterinary and human vaccine formulations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SPI Pharma and Anek Prayog Form Strategic Partnership for Global Launch of Lubripharm™ Pro, combining expertise for pharmaceutical delivery solutions.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

NutraFood Poland Partnership with Lehmann & Voss&Co. for market presence at EXPO XXI Warsaw trade show.

4APC (Asia Pulp & Paper)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AB Enzymes strategic partnership for Pulp & Paper Solutions in Asia, providing enzyme solutions for the pulp and paper industry across the Asia-Pacific region.

abfingredients.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

ABITEC Corporation and DKSH expansion of lipid distribution agreement for broader market reach in lipid ingredients.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

ABITEC Corporation appointment of Palmer Holland as US-based distribution partner for specialty lipid products.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

ABITEC Corporation integration and brand refresh with Larodan AB Research Grade Lipids following successful acquisition.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

ABITEC Corporation enters into Memorandum of Understanding with Luca AICell Inc. for potential technology collaboration.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diversified food and agriculture major with food ingredients, animal nutrition and bio-industrial businesses; competes with AB Enzymes in food processing, with Ohly in savory, and with PGP in extruded ingredients.

TypeDirect peer
Description

Global yeast and fermentation specialist producing yeast extracts, savory flavors and fermentation-derived food ingredients; the most direct competitor to Ohly's yeast-extract franchise and overlapping food-manufacturer customer base.

TypeDirect peer
Description

Taste & nutrition specialist supplying food and beverage manufacturers with flavor systems, functional ingredients and yeast extracts; comparable to Ohly and PGP savory/culinary ingredients for food-manufacturer customers.

TypeDirect peer
Description

Pharmaceutical CDMO and ingredients supplier with leading excipient, adjuvant and drug-delivery capabilities; directly comparable to SPI Pharma's pharmaceutical excipients, taste-masking and vaccine adjuvant portfolio.

TypeDirect peer
Description

Global nutrition, health and ingredients group offering enzymes, vitamins, flavors, and pharmaceutical excipients to food, pharma and personal-care manufacturers; directly comparable across AB Enzymes, Biotexia and SPI Pharma product lines.

TypeDirect peer
Description

Global specialty ingredient supplier of starches, sweeteners, and functional ingredients to food and beverage manufacturers; comparable because Jeremy Xu (now ABFI CEO) previously ran Ingredion's Global Healthful Solutions and the businesses serve overlapping food/health customers.

TypeDirect peer
Description

Specialty food ingredients and solutions provider focused on sweeteners, texturants and fortification; comparable to AB Enzymes bakery/beverage enzymes and functional food ingredient positioning.

TypeDirect peer
Description

Specialty chemicals and ingredients supplier serving personal care, pharma and food with lipid-based excipients and adjuvants; comparable to ABITEC's specialty lipids and SPI Pharma's pharmaceutical excipients businesses.

TypeBroad incumbent
Description

Large global agribusiness with a sizable Nutrition segment offering flavors, specialty proteins, and enzymes for food, beverage and health customers; comparable as a broad incumbent competing with multiple ABFI sub-brands.

TypeBroad incumbent
Description

Diversified ingredients giant spanning food, beverage, health and biosciences including enzymes, cultures, flavors and excipients; overlaps with ABFI across enzymes, savory flavors (Ohly) and pharma excipients as a much larger peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ABF Ingredients

Specialty Ingredientsabfingredients.com

ABF Ingredients is the specialty ingredients division of Associated British Foods plc, operating six business units (AB Enzymes, ABITEC, Biotexia, Ohly, PGP International, SPI Pharma) that supply enzymes, yeast extracts, specialty lipids, pharmaceutical excipients, bioactives, and extruded crisps to food, pharmaceutical, health/nutrition, animal health, and industrial manufacturers across 28+ countries.

What ABF Ingredients does

ABF Ingredients (ABFI) is the specialty ingredients division of Associated British Foods plc, a London-listed conglomerate, operating as a private subsidiary headquartered in Peterborough, United Kingdom with 501-1,000 employees. The company is structured as six empowered business units — AB Enzymes, ABITEC Corporation, Biotexia, Ohly, PGP International, and SPI Pharma — each focused on a distinct ingredient technology and end-market. ABFI's portfolio spans enzymes for food, feed, and industrial processing; specialty lipids and emulsifiers for pharmaceutical, nutritional, and food applications; yeast extracts and savory flavors (Ohly, with 190 years of Hamburg production heritage); extruded grain and protein crisps; pharmaceutical excipients, vaccine adjuvants, and drug delivery systems; and bioactives for health and nutrition applications. Customer end-markets include food manufacturers, pharmaceutical companies, health and nutrition brands, animal feed manufacturers, and industrial processors, served across at least 28 countries in North America, Europe, Latin America, Asia, Africa, and Oceania. Technology differentiation is anchored in long-tenured proprietary processes (yeast fermentation, enzyme engineering, lipid chemistry) rather than AI or software; products such as VERON POLARUM (enzyme), ActiMask (taste masking), and Q-SAP (saponin adjuvants) reflect the company's R&D positioning.

The business operates a B2B specialty ingredients model, generating revenue through negotiated multi-year supply contracts with manufacturers rather than standardized list pricing. Distribution combines direct enterprise sales with channel partnerships (DKSH for lipids in select regions, Palmer Holland in the US, Lehmann & Voss&Co. in Poland) and customer-facing infrastructure such as Ohly's Customer Innovation Center in Chicago. Recent strategic posture is one of capacity expansion and portfolio consolidation: a $247-270 million Ohly biomanufacturing campus is under development in Eau Claire, Wisconsin (three phases through 2035), a new spray drying tower has opened in Hamburg, three health and nutrition brands (Fytexia, ABbiotek Health, Anzchem) have been unified into a single business, and the parent ABF announced a 2026 demerger separating Primark retail from the Food and Ingredients group (FoodCo). FY2023 segment revenue was £2,157 million with £214 million adjusted operating profit; FY2025 segment revenue declined 2% (1% at constant currency) due to US consumer weakness in bakery ingredients and increased investment. Leadership transitioned in April 2024 when Jeremy Xu succeeded Fabienne Saadane-Oaks as CEO.

ABF Ingredients firmographics

Firmographics
Name
ABF Ingredients
Legal name
ABF Ingredients Limited
Website
https://abfingredients.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
501–1,000 employees
Short description
ABF Ingredients is the specialty ingredients division of Associated British Foods plc, operating six business units (AB Enzymes, ABITEC, Biotexia, Ohly, PGP International, SPI Pharma) that supply enzymes, yeast extracts, specialty lipids, pharmaceutical excipients, bioactives, and extruded crisps to food, pharmaceutical, health/nutrition, animal health, and industrial manufacturers across 28+ countries.
Ownership category
akta.pro rank

ABF Ingredients industry classification

Industry
Product category
Specialty Ingredients
NAICS
Food Manufacturing (311), Fats and Oils Refining and Blending (311225), Flavoring Syrup and Concentrate Manufacturing (31193)
SIC
Miscellaneous Food Preparations & Kindred Products (2090), Food And Kindred Products (2000), Fats & Oils (2070)
akta.pro primary industry
Food-Grade Additives & Functional Ingredients Trading/Wholesale (AFAIAKAI)
akta.pro secondary industries
Baking Ingredients & Mixes Wholesale (Flour, Sugar, Yeast, Improvers) (AFAIAFAD), Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium) (AFAKAJAD), Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

  • Specialty ingredients supplier
  • Enzyme technology
  • Yeast extracts
  • Pharmaceutical excipients
  • Specialty lipids

Where ABF Ingredients is headquartered

Location

Headquarters

HQ city
Peterborough
HQ country
United Kingdom
HQ region
Europe

Offices9 records

Markets served

ABF Ingredients business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Specialty Ingredients B2B Sales: ABF Ingredients generates revenue through the sale of specialty ingredients to food, pharmaceutical, health and nutrition, animal health, and industrial manufacturers. The company operates six business units serving diverse markets with a focus on functional ingredients, enzymes, yeast extracts, pharmaceutical excipients, and specialty lipids.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B specialty ingredients pricing - negotiated contracts

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

ABF Ingredients product offering

Product offering

Core offering

ABF Ingredients is the specialty ingredients division of Associated British Foods, comprising six empowered businesses that manufacture and sell functional ingredients to industrial customers. The portfolio spans enzymes (AB Enzymes), specialty lipids and emulsifiers (ABITEC), bioactives (Biotexia), yeast extracts and savory flavors (Ohly), extruded grain and protein crisps (PGP International), and pharmaceutical excipients and delivery systems (SPI Pharma). Products are sold to food, pharmaceutical, health and nutrition, animal health, and industrial manufacturers globally.

Product overview

ABF Ingredients (ABFI) is the specialty ingredients division of Associated British Foods, comprising six empowered businesses offering a diverse portfolio of specialty ingredients across Health, Nutrition, Food, Animal Health, Pharmaceuticals, and Industrial sectors. The portfolio includes AB Enzymes (enzyme solutions), ABITEC Corporation (specialty lipids and emulsifiers), Biotexia (health and nutrition ingredients), Ohly (yeast extracts and savory flavors), PGP International (protein-based ingredients and extruded crisps), and SPI Pharma (pharmaceutical excipients and delivery systems). Products span antacid actives, bioactives, culinary powders, enzymes, extruded crisps, pharmaceutical excipients, specialty flours, specialty lipids, surfactants and emulsifiers, taste masking technology (ActiMask), vaccine adjuvants, and yeast extracts. The unified Health & Nutrition business combines Fytexia, ABbiotek Health, and Anzchem focusing on immune health, digestive health, mobility health, metabolic health, brain health, and women's health.

Differentiator

Problem solved

Functional benefit

Brands

  • Ohly: Specialty yeast extracts and yeast products for food flavor, pharmaceutical, and industrial applications
  • AB Enzymes
  • ABITEC
  • PGP International
  • SPI Pharma
  • Biotexia

Products and services

  • AB Enzymes Enzyme solutions for food, animal feed, and industrial applications, including baking, beverages, grain and oil seed processing, cleaning products, lubricants, and textiles.
  • ABITEC Corporation Specialty lipids and emulsifiers for pharmaceutical, food, nutritional, and industrial applications, including surfactants and functional lipid solutions.
  • Biotexia Health and nutrition ingredients business focused on scientifically supported bioactives for human health applications including weight management, immune health, and quality of life.
  • Ohly Yeast extracts and specialty ingredients for savory flavors, food, beverage, pharmaceutical, and industrial applications, with 190 years of production heritage in Hamburg.
  • PGP International Protein-based ingredients and extruded grain and protein crisps for snack and food applications including alternative proteins and specialty flours.
  • SPI Pharma Pharmaceutical excipients, vaccine adjuvants, and drug delivery systems including taste masking technology and parenteral products for pharmaceutical formulations.
  • Antacid Actives Active pharmaceutical ingredients for antacid formulations used by pharmaceutical manufacturers.
  • Bioactives Bioactive ingredients for health and nutrition applications supporting wellness and functional food formulations.
  • Culinary Powders Powder-based culinary ingredients for food processing and manufacturing applications.
  • Extruded Crisps Extruded grain and protein crisps for snack and food applications.
  • Enzymes Enzyme products for various industrial, food, and feed applications including VERON POLARUM for butter-rich recipes.
  • Pharmaceutical Excipients Excipient ingredients for pharmaceutical formulations and drug delivery systems.
  • Specialty Flours Specialty flour products for food manufacturing and processing.
  • Specialty Lipids Specialty lipid ingredients for pharmaceutical, nutritional, and food applications.
  • Surfactants and Emulsifiers Surface-active agents and emulsifiers for various industrial and food applications.
  • Taste Masking Technology Technologies to mask unpleasant tastes in pharmaceutical and nutritional products, including ActiMask.
  • Vaccine Adjuvants Adjuvant ingredients for vaccine formulations including saponin-based adjuvants for human and veterinary vaccines.
  • Yeast Extracts Yeast extract products for flavor enhancement and nutritional applications, including high nucleotide yeast extracts.

Quantifiable outcome

  • 85% improvement in safety metrics since the HSE Awards programme's inception
  • +2 more outcomes

Companies that use ABF Ingredients

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

ABF Ingredients technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

ABF Ingredients partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Q-Vant BiosciencescoreStrategic or Co-development Partner · 17 October 2023SPI Pharma and Q-Vant Biosciences partnership combining Q-Vant's sustainable saponin extraction technology with SPI's global reach and pharmaceutical servicing expertise. Includes investment in expansion of Q-Vant's proprietary Q-SAP technology and exclusive commercial agreement for sustainable saponin adjuvants for veterinary and human vaccine formulations.
  • Anek PrayogcoreStrategic or Co-development PartnerSPI Pharma and Anek Prayog Form Strategic Partnership for Global Launch of Lubripharm™ Pro, combining expertise for pharmaceutical delivery solutions.
  • Lehmann & Voss&Co.minorChannel Partner/ Reseller/ DistributorNutraFood Poland Partnership with Lehmann & Voss&Co. for market presence at EXPO XXI Warsaw trade show.
  • APC (Asia Pulp & Paper)coreStrategic or Co-development PartnerAB Enzymes strategic partnership for Pulp & Paper Solutions in Asia, providing enzyme solutions for the pulp and paper industry across the Asia-Pacific region.
  • DKSHcoreChannel Partner/ Reseller/ DistributorABITEC Corporation and DKSH expansion of lipid distribution agreement for broader market reach in lipid ingredients.
  • Palmer HollandcoreChannel Partner/ Reseller/ DistributorABITEC Corporation appointment of Palmer Holland as US-based distribution partner for specialty lipid products.
  • Larodan ABcoreOEM/ Whitelabel/ Licensing PartnerABITEC Corporation integration and brand refresh with Larodan AB Research Grade Lipids following successful acquisition.
  • Luca AICell Inc.minorStrategic or Co-development PartnerABITEC Corporation enters into Memorandum of Understanding with Luca AICell Inc. for potential technology collaboration.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

ABF Ingredients competitors and assessment

Company assessment

Broad incumbents

  • Cargill: Diversified food and agriculture major with food ingredients, animal nutrition and bio-industrial businesses; competes with AB Enzymes in food processing, with Ohly in savory, and with PGP in extruded ingredients.
  • ADM (Archer Daniels Midland): Large global agribusiness with a sizable Nutrition segment offering flavors, specialty proteins, and enzymes for food, beverage and health customers; comparable as a broad incumbent competing with multiple ABFI sub-brands.
  • International Flavors & Fragrances (IFF): Diversified ingredients giant spanning food, beverage, health and biosciences including enzymes, cultures, flavors and excipients; overlaps with ABFI across enzymes, savory flavors (Ohly) and pharma excipients as a much larger peer.

Direct peers

  • Lesaffre: Global yeast and fermentation specialist producing yeast extracts, savory flavors and fermentation-derived food ingredients; the most direct competitor to Ohly's yeast-extract franchise and overlapping food-manufacturer customer base.
  • Kerry Group: Taste & nutrition specialist supplying food and beverage manufacturers with flavor systems, functional ingredients and yeast extracts; comparable to Ohly and PGP savory/culinary ingredients for food-manufacturer customers.
  • Lonza Group: Pharmaceutical CDMO and ingredients supplier with leading excipient, adjuvant and drug-delivery capabilities; directly comparable to SPI Pharma's pharmaceutical excipients, taste-masking and vaccine adjuvant portfolio.
  • dsm-firmenich: Global nutrition, health and ingredients group offering enzymes, vitamins, flavors, and pharmaceutical excipients to food, pharma and personal-care manufacturers; directly comparable across AB Enzymes, Biotexia and SPI Pharma product lines.
  • Ingredion: Global specialty ingredient supplier of starches, sweeteners, and functional ingredients to food and beverage manufacturers; comparable because Jeremy Xu (now ABFI CEO) previously ran Ingredion's Global Healthful Solutions and the businesses serve overlapping food/health customers.
  • Tate & Lyle: Specialty food ingredients and solutions provider focused on sweeteners, texturants and fortification; comparable to AB Enzymes bakery/beverage enzymes and functional food ingredient positioning.
  • Croda International: Specialty chemicals and ingredients supplier serving personal care, pharma and food with lipid-based excipients and adjuvants; comparable to ABITEC's specialty lipids and SPI Pharma's pharmaceutical excipients businesses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

ABF Ingredients social profiles

Digital presence

ABF Ingredients financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ABF Ingredients leadership team

Management profile

Number of profiles

Profiles1 record

ABF Ingredients subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

ABF Ingredients funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ABF Ingredients M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABF Ingredients

What does ABF Ingredients do?

ABF Ingredients is the specialty ingredients division of Associated British Foods, comprising six empowered businesses that manufacture and sell functional ingredients to industrial customers. The portfolio spans enzymes (AB Enzymes), specialty lipids and emulsifiers (ABITEC), bioactives (Biotexia), yeast extracts and savory flavors (Ohly), extruded grain and protein crisps (PGP International), and pharmaceutical excipients and delivery systems (SPI Pharma). Products are sold to food, pharmaceutical, health and nutrition, animal health, and industrial manufacturers globally.

Is ABF Ingredients a public or private company?

ABF Ingredients is a private company. It is classified as corporate owned and is currently operating.

When was ABF Ingredients founded?

ABF Ingredients was founded in 2003. It employs 501 to 1,000 people.

Where is ABF Ingredients based?

ABF Ingredients is headquartered in Peterborough, United Kingdom, in the Europe region.

How does ABF Ingredients make money?

One revenue line is on record: specialty Ingredients B2B Sales.

Who are ABF Ingredients's main competitors?

Broad incumbents on record are Cargill, ADM (Archer Daniels Midland) and International Flavors & Fragrances (IFF). Direct peers are Lesaffre, Kerry Group, Lonza Group, dsm-firmenich, Ingredion, Tate & Lyle and Croda International.

Does ABF Ingredients have an API?

No public API is recorded for ABF Ingredients.

What industry is ABF Ingredients in?

ABF Ingredients's product category is Specialty Ingredients. Its primary akta.pro industry code is AFAIAKAI, Food-Grade Additives & Functional Ingredients Trading/Wholesale, with a secondary code of AFAIAFAD, Baking Ingredients & Mixes Wholesale (Flour, Sugar, Yeast, Improvers). Its NAICS code is 311 and its SIC code is 2090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CultureABF Ingredients To Invest $274M In Eau Claire Facility As Part...ABF Ingredients has selected Eau Claire, Wisconsin as the location for a new 22,000-square-foot biomanufacturing facility for its Ohly business unit, representing a total $247 million investment that will create 90-100 jobs with wages ranging from $24-$60/hour. Construction will begin this year with three phases of development planned through 2035, and the facility will serve as Ohly's North American campus. The location was chosen after a multi-year evaluation citing proximity to ABFI's existing operations in Boyceville and the region's strong infrastructure.Nutraceutical Business ReviewBiotexia announces new brand identity as part of strategic growth ambitionsABF Ingredients has merged its health and nutrition divisions—ABbiotek Health, Fytexia, and Anzchem—into a unified entity named Biotexia to drive strategic growth in the supplements market. The new brand will make its debut at Vitafoods Europe in Barcelona, showcasing its clinically supported ingredient portfolio including DNF 10 and Sinetrol®.AbfingredientsABF Ingredients has acquired Fytexia GroupABF Ingredients has acquired Fytexia Group, a life science company specializing in bioactive compounds for dietary supplements. This strategic acquisition aims to expand ABFI’s product portfolio and capabilities within the pharmaceutical, nutritional, and food markets. The deal brings Fytexia's expertise in polyphenols and propolis extraction into ABFI's global network of specialty ingredient businesses.